Skip to content

Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients

Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients: A Double Blind Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04487613
Enrollment
88
Registered
2020-07-27
Start date
2021-03-15
Completion date
2022-06-30
Last updated
2022-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Women

Brief summary

The purpose of this study is to assess the effect of Moringa oleifera leaf capsule in increasing breast milk volume

Interventions

450 mg capsule

DRUGPlacebo

placebo capsule

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Postpartum women

Exclusion criteria

* Postpartum women with contraindication for breast feeding such as HIV, untreated tuberculosis, on chemotherapeutic drugs, on radioactive drugs, substance abuse. * Postpartum women with unstable conditions such as postpartum hemorrhage.

Design outcomes

Primary

MeasureTime frameDescription
Breast milk volume at postpartum day 3day 3Breast milk volume measuring by weighting the infant fully clothed before and after each feeding with an electronic weigh scale for the period of 24 hours (at postpartum day 3). The sum of weight difference in gram was then converted to breast milk volume in milliliter (1 g = 1 mL).

Secondary

MeasureTime frameDescription
percentage of good satisfaction3 dayssatisfaction evaluated by 5 scales
quality of life scores3 daysQuality of life measuring by Thai version of WHO-QOL questionaire
side effects3 dayspercentage of side effects such as headache, nausea/vomiting
Compliance3 dayspercentage of complete drug use

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026